Literature DB >> 21180524

How should We Classify and Treat Patients with Functional Gastrointestinal Disorders?

John T McLaughlin1.   

Abstract

Entities:  

Year:  2008        PMID： 21180524      PMCID： PMC3002504          DOI： 10.1177/1756283X08098267

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN： 1756-283X            Impact factor:   4.409


× No keyword cloud information.
  5 in total

Review 1.  Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management.

Authors:  Eamonn M M Quigley
Journal:  J Dig Dis       Date:  2007-02       Impact factor: 2.325

2.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.

Authors:  R C Spiller; D Jenkins; J P Thornley; J M Hebden; T Wright; M Skinner; K R Neal
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

Review 3.  Functional bowel disorders.

Authors:  George F Longstreth; W Grant Thompson; William D Chey; Lesley A Houghton; Fermin Mearin; Robin C Spiller
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

Review 4.  Postinfectious irritable bowel syndrome.

Authors:  Robin C Spiller
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

Review 5.  Peripheral and central mechanisms of visceral sensitization in man.

Authors:  P Anand; Q Aziz; R Willert; L van Oudenhove
Journal:  Neurogastroenterol Motil       Date:  2007-01       Impact factor: 3.598
  5 in total
  2 in total

1.  Immune Activation in Functional Gastrointestinal Disorders.

Authors:  Grace Burns; Jennifer Pryor; Gerald Holtmann; Marjorie M Walker; Nicholas J Talley; Simon Keely
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-10

2.  An Open-label, Multicenter Study to Assess the Efficacy and Safety of a Novel Probiotic Blend in Patients With Functional Gastrointestinal Symptoms.

Authors:  Lucinda A Harris; Brooks D Cash; Karim Moftah; Howard Franklin
Journal:  J Clin Gastroenterol       Date:  2022 May-Jun 01       Impact factor: 3.062
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.